LIVERMORE, Calif.– S2 Genomics, a manufacturer and provider of automated tissue sample preparation systems, and the RIKEN Center for Integrative Medical Sciences (IMS), a leading genomics research institute, today announced that RIKEN IMS has joined the S2 Genomics Early Technology Access Program to evaluate and further develop single cell sequencing applications on the S2 Genomics […]

Lausanne-Switzerland and Utrecht-the Netherlands The University of Lausanne (UNIL) and the Lausanne University Hospital (CHUV) have acquired MILabs latest in-vivo optical imaging and diagnostic X-ray CT systems. The systems will be installed in the In-Vivo Imaging Facility (IVIF) and serve a dual optical imaging function. Aptly named the Duet Optical Imaging Module, the system can […]

NANJING, China and EMERYVILLE, Calif. — GenScript Biotech Corp., the world’s leading pharmaceutical CDMO company, announced today that the company is adopting a state-of-the-art optofluidic single-cell platform known as the Beacon® platform. The platform was developed by Berkeley Lights, Inc., a company committed to helping customers find the best cells to accelerate the use of cell-based products. […]

 Investment in resources to meet demand for large-scale supply of patented biocompatible surfactan Pico-Surf offers reliable, highly stable and high-quality droplet generation and processing for microfluidic applications Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today announced investment in the production and supply of its proprietary biocompatible […]

MENLO PARK, Calif. — Ionpath Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope™ multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in immuno-oncology. IONpath has previously provided custom research services to leading academic and pharmaceutical organizations as part of an Early […]

New Center of Excellence to Advance Highly Multiplexed Tissue Imaging in Translational and Clinical Cancer Research SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will establish a new Center of Excellence (CoE) for Imaging Mass Cytometry™ at Georgetown […]

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) — Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences company, has selected Fluidigm’s CyTOF® technology and the industry-leading Maxpar® Direct™ Immune Profiling Assay™ to develop highly multiplexed immune profiling services. Setting an industry first, high-multiplex mass cytometry enables clinical researchers to simultaneously profile […]

NEWARK, Calif. — Intabio, a developer of instrumentation systems for biotherapeutic precision analysis and quality assessment throughout bioproduction, today announced a Series B investment of $18 million. The financing round was led by Northpond Ventures, with additional funds coming from Genoa Ventures and Vertical Venture Partners. In a testament to Intabio’s steady progress, the step-up valuation […]

PASADENA, CA / De Novo Software, the premier provider of both research and clinical cytometry data analysis solutions, announced today that FCS Express™ will be bundled with every new ZE5 Cell analyzer sold by Bio-Rad Laboratories, Inc., (BIO) (BIO-B), a global leader of life science research and clinical diagnostic products. The non-exclusive partnership between Bio-Rad […]

Aimed at achieving a paradigm shift in Oncology research by imaging and quantifying fluorescent signals deep in the brain of of animal models and to quantitate the molecular response of biomarkers to therapy Nicosia, Cyprus and Utrecht, the Netherlands EPOS-Iasis Research and Development Ltd and the University of Cyprus UCY have acquired a MiLabs Hybrid […]